Apple has received official confirmation for one of the main features of its new watches: the ability to understand how hard your heart is beating.
The new feature of hypertension is designed so that people have high blood pressure (hypertension). Unlike some tools, it does not work through the button that compresses the arm, but can instead detect the symptoms of the disease using data collected by the clock heart rate.
Apple said high blood pressure is a corrective risk factor for heart attacks, stroke and kidney disease and affects 1.3 billion adults around the world. But it is often not diagnosed because it requires special equipment to stain and can be easily lost.
Apple says a new feature for identifying wearers that may be at risk of hypertension by monitoring their heart rate data within 30 days. Then users are notified if these data indicate that they indicate high blood pressure symptoms.
The company has announced that it expects to inform more than one million people in the first year of its introduction.
The tool was announced this week at Apple’s “Awe Droping” event, where new iPhone, AirPods and Apple watches are updating. However, this feature is shown as part of those new watches, it will be available for wearables since the Apple Watch 9 series, released two years ago.
At the time of launch, Apple announced that it will soon be expected to confirm FDA, but now this is granted and this feature will be available with the launch of new watches.
Apple’s increasing focus on health means that some of its recent features need confirmation of regulators before being submitted to customers. For example, recent updates include features that, for example, convert AirPods Pro to hearing aid.
While Apple has received a quick approval of the FDA in the United States, regulators of other countries must agree before the tools can be sold elsewhere. This means that rolling a feature like this can often be stunned even after Apple’s availability.
Similar features with Apple’s blood pressure monitoring tool have already been controversial when confirming the FDA. For example, the Fitness Technology Company is locked in the dispute with the regulator as to whether the “blood pressure insight” tool should be permitted by the FDA as a medical device.
Wop has argued that this tool is “a health character, not a medical device” and is not focused on identifying specific conditions. But the FDA has said that “it is inherently associated with the diagnosis of hypertension and high blood pressure, so Viop’s claim that it is not intended for medical use is incorrect.
